Cell Impact AB Series B | Income Statement
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
3,321.10
3,533.40
1,858.30
1,825.70
1,536.20
Cost of Goods Sold (COGS) incl. D&A
10,952.20
11,429.20
9,294.60
10,203.50
19,641.60
Gross Income
7,631.10
7,895.80
7,436.30
8,377.80
18,105.40
SG&A Expense
102.70
-
-
35.90
-
EBIT
7,733.80
7,895.80
7,436.30
8,408.10
18,105.40
Non Operating Income/Expense
102.90
115.30
60.90
44.70
61.50
Interest Expense
-
-
7.00
221.90
248.10
Pretax Income
7,598.10
7,749.00
7,382.00
8,584.30
18,291.90
Consolidated Net Income
7,598.10
7,749.00
7,382.00
8,584.30
18,291.90
Net Income
7,598.10
7,749.00
7,382.00
8,584.30
18,291.90
Net Income After Extraordinaries
7,598.10
7,749.00
7,382.00
8,584.30
18,291.90
Net Income Available to Common
7,598.10
7,749.00
7,382.00
8,584.30
18,291.90
EPS (Basic)
1.41
0.78
0.74
0.91
1.31
Basic Shares Outstanding
5,387.30
9,945.80
9,945.80
9,434.80
13,905.30
EPS (Diluted)
1.41
0.78
0.74
0.91
1.32
Diluted Shares Outstanding
5,387.30
9,945.80
9,945.80
9,434.80
13,905.30
EBITDA
5,848.00
5,827.80
6,942.20
7,925.80
16,943.70
Other Operating Expense
-
-
-
5.50
-
Non-Operating Interest Income
32.80
31.50
0.40
1.00
0.10
About Cell Impact AB
View Profile
